Precigen

Intrexon Corporation
	File:Intrexon Logo 2018.png
Traded as	NYSE: XON; Russell 2000 Component
Industry	Biotechnology
Founded	May 21, 1998; 26 years ago
Headquarters	Germantown , United States
Website	dna.com

Intrexon Corporation (NYSE: XON) is an American biotechnology company, and its chairman and CEO is Randal J. Kirk.

Intrexon was founded in 1998, and is headquartered in Germantown, Maryland.^[1]^[2] With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.^[3]

History

In 2015, Intrexon purchased Oxitec, a maker of gene drive technology for $160 million.^[4]

References

^ "Intrexon Corporation: Private Company Information". Bloomberg. Retrieved 2017-06-26.
^ "Intrexon Corp (XON) Company Profile". Reuters.com. Retrieved 2017-06-26.
^ "FAQ | Intrexon". Intrexon InvestorRoom. Retrieved 2018-03-28.
^ Nickel, Rod (15 September 2015). "Market turbulence or not, North American investors plow into farm tech". Reuters. Retrieved 9 October 2015.

External links

Official website

[1] "Intrexon Corporation: Private Company Information". Bloomberg. Retrieved 2017-06-26.

[2] "Intrexon Corp (XON) Company Profile". Reuters.com. Retrieved 2017-06-26.

[3] "FAQ | Intrexon". Intrexon InvestorRoom. Retrieved 2018-03-28.

[4] Nickel, Rod (15 September 2015). "Market turbulence or not, North American investors plow into farm tech". Reuters. Retrieved 9 October 2015.

[1]

[2]

[3]

[4]